NOV 03, 2016 06:00 AM PDT

IQCP is a four letter word

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Assistant Professor Pathology, Director of Chemistry, Immunology, Toxicology, and Point of Care; Ohio State University Wexner Medical Center
      Dr. Cotten is Director for Chemistry, Immunology, Toxicology and Point-of-Care testing at the Ohio State University Wexner Medical Center and Assistant Professor in Pathology at the Ohio State University. He received his PhD in Pharmaceutical Sciences from the School of Pharmacy at the University of North Carolina at Chapel Hill where he also completed his training in clinical chemistry in the Department of Pathology. Dr. Cotten is board certified in Clinical Chemistry by the American Board of Clinical Chemistry. He has served as the chair of the AACC Ohio Valley Local Section and is currently the newsletter editor and online community moderator for the new Mass Spectrometry and Separation Sciences (MS3) Division of The American Association for Clinical Chemistry. His primary research interests include drug testing in alternative matrices and operational efficiency metrics for clinical laboratories.


    IQCP represents a new approach to quality control for clinical laboratories.  Beginning in 2016 clinical laboratories were tasked with developing individualized quality control plans for a variety of testing platforms.  This session will review the fundamentals of IQCP and how laboratories can handle implementing individualized quality control in their labs. Guidelines from CMS and CAP will be compared in regards to documentation and expectations for each accrediting organization.  Additional methods to audit the effectiveness of a labs IQCP will be explored.

    After attending this session participants should be able to:
    1. Define the components of an IQCP
    2. Develop an IQCP for a laboratory test
    3. Identify the differences between CMS and CAP documentation for IQCPs

    Show Resources
    Loading Comments...